Abstract

Purpose To describe the clinical features of acute nongranulomatous anterior uveitis (NGAU) patients and to estimate the prevalence of concomitant spondyloarthritis (SpA). Methods Retrospective study of consecutive patients affected by NGAU referred to the Ocular Immunology Unit of the AUSL-IRCCS di Reggio Emilia, Italy, between January 2016 and January 2019. All patients underwent ophthalmic evaluation and blood test with HLA-B27 typing and were referred to a rheumatologist to identify any undiagnosed SpA. SpA was classified according to the Assessment of SpondyloArthritis international Society (ASAS) criteria in axial or peripheral SpA. Patients were divided into two groups: NGAU with associated SpA (SpA+) and NGAU without SpA (SpA-). Clinical and demographic features of the two groups, including sex, HLA-B27, family history of rheumatic disease, uveitis laterality, course, and severity of ocular inflammation, complications, and treatment, were compared. Results Ninety-nine patients with NGAU were enrolled, of whom 36 (36%) with a diagnosis of SpA: 14 with peripheral SpA and 22 with axial SpA. The prevalence of SpA was higher in HLA-B27-positive patients than in HLA-B27-negative patients (50% vs. 15%, p < 0.0001). The multivariate logistic regression (R2 = 0.28) for SpA diagnosis identified as significant predictive factors: age at diagnosis (odds ratio [OR] = 0.95, 95% confidence interval [CI]: 0.91-0.99) and HLA-B27+ (OR = 5.32, 95% CI: 1.80-15.70). Conclusions Our results confirmed the high prevalence of undiagnosed SpA in patients with NGAU, suggesting that, regardless of HLA-B27 status, in the presence of IBP and/or peripheral arthritis, patients with NGAU must be referred to the rheumatologist to allow earlier diagnosis.

Highlights

  • Acute anterior uveitis (AAU) is the most common type of uveitis worldwide, with higher prevalence in Western countries, where it accounts for approximately 50-92% of cases [1]

  • This study evaluated the ophthalmological and rheumatological clinical features as well as the demographics and genetics (HLA-B27) of patients with nongranulomatous anterior uveitis (NGAU) to differentiate between NGAU associated with SpA (SpA+) and NGAU without SpA (SpA-) and to help ophthalmologists to appropriately select patients for rheumatology referral

  • A well-structured screening of patients affected by NGAU could allow early diagnosis, considering that the mean diagnostic delay of SpA from symptom onset ranges from 4.9 to 6.8 years [15, 16]

Read more

Summary

Introduction

Acute anterior uveitis (AAU) is the most common type of uveitis worldwide, with higher prevalence in Western countries, where it accounts for approximately 50-92% of cases [1]. Age (yrs) Age < 45 yrs Age at uveitis diagnosis (yrs) Uveitis diagnostic delay (mo) Sex. Legend: SD: standard deviation; IQR: interquartile range; SpA: spondyloarthritis; F: female; M: male; BMI: body max index; HLA: human leukocyte antigen; IBP: inflammatory back pain; ASAS: Assessment of SpondyloArthritis international Society; IBD: inflammatory bowel disease. Legend: BMI: body max index; SpA: spondyloarthritis; HLA: human leukocyte antigen; IBP: inflammatory back pain; ASAS: Assessment of SpondyloArthritis international Society; IBD: inflammatory bowel disease. Legend: SD: standard deviation; IQR: interquartile range; BMI: body max index; SpA: spondyloarthritis; HLA: human leukocyte antigen; IBP: inflammatory back pain; ASAS: Assessment of SpondyloArthritis international Society; IBD: inflammatory bowel disease. Legend: SpA: spondyloarthritis; SD: standard deviation; IQR: interquartile range; BMI: body max index; M: male; F: female; HLA: human leukocyte antigen; IBP: inflammatory back pain; ASAS: Assessment of SpondyloArthritis international Society; IBD: inflammatory bowel disease. This study evaluated the ophthalmological and rheumatological clinical features as well as the demographics and genetics (HLA-B27) of patients with NGAU to differentiate between NGAU associated with SpA (SpA+) and NGAU without SpA (SpA-) and to help ophthalmologists to appropriately select patients for rheumatology referral

Materials and Methods
Results
Discussion
Conflicts of Interest
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call